The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy - A prospective, randomized, double-blind, placebo-controlled study
Jd. Nielsen et al., The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy - A prospective, randomized, double-blind, placebo-controlled study, SC J UROL N, 34(3), 2000, pp. 194-198
Objective: An increase in the loss of blood after ingestion of acetylsalicy
lic acid (ASA) has been reported after several types of surgery, but random
ized placebo-controlled studies have exclusively been performed after coron
ary artery bypass surgery. The reported effects of ASA on bleeding after tr
ansurethral prostatectomy (TURP) have been conflicting. We have studied the
effect of low doses of ASA (150 mg) on bleeding after TURF in a prospectiv
e, randomized, double-blind, placebo-controlled trial. Patients and methods
: Patients were randomized to receive either 150 mg ASA (n = 26) or placebo
(n = 27) 10 days before surgery. The weight of resected tissue, operation
time and blood loss, transfusion requirements and complications were record
ed. Results: There was no significant difference in the median operative bl
ood loss between the: groups (p = 0.528), but postoperatively the blood los
s in the ASA group (median 284: quartiles 196-660 mi was significantly high
er than in the placebo group (median 144; quartiles 75-379 mi), (p = 0.011)
. No significant difference was observed between the groups regarding the a
mount of resected tissue (p = 0.209) or the operating lime (p = 0.297). in
both groups the operative blood loss was significantly related to the amoun
t of resected tissue (p < 0.005) and the operating time (p< 0.005). No sign
ificant difference in transfusion requirements (p= 0.280), time to catheter
removal (p= 0.455) and hospital stay (p = 0.820) were observed between the
groups. Conclusion: Long-term low-dose ASA therapy is associated with a si
gnificant increase in the postoperative blood loss after TURF, and although
no significant difference in transfusion requirements was observed more un
its of blood were used in the ASA group. We advise that ASA therapy should
be withdrawn 10 days before TURF.